AIHW Board AIHW senior staff Annual report Capability statement Collaboration AIHW corporate plan 2016–17 to 2019–20 Customer care charter FOI - freedom of information Indexed list of files Organisation chart Presentations Privacy of data Public consultation Public Interest Disclosure Strategic Directions 2011-2014 Tenders
By category Ageing, disability & carers Families & children Hospitals Housing & homelessness Indigenous Australians Population groups Risk factors, diseases & death Services, workforce & spending
By subject Adoptions Aged care Ageing Alcohol & other drugs Arthritis & musculoskeletal conditions Asthma Australia's health Australia's welfare Burden of disease Cancer Cardiovascular disease Child health, development & wellbeing Child protection Children's services Chronic diseases
Chronic kidney disease Chronic respiratory conditions COPD Deaths Dementia Dental & oral health Diabetes Disability Expenditure Eye health Food & nutrition Health indicators Health performance Homelessness Hospitals Housing assistance Indigenous Australians Injury Life expectancy
Male health Mental health Mothers & babies National health priority areas Overweight & obesity Palliative care Population health Primary health care Prisoner health Risk factors Rural health Safety & quality of health care Veterans' health Workforce Youth health & wellbeing Youth justice
In other sections Data Publications Contact AIHW
Publications CatalogueOrdering publicationsForthcoming publications Online reports Rate our publication effectivenessSubscribe to release notices
By subject Adoptions Aged care Ageing Alcohol & other drugs AIHW annual reports Arthritis & musculoskeletal conditions Asthma Australia's health Australia's welfare Burden of disease Cancer Cardiovascular disease Child health, development & wellbeing Child protection Children's services Chronic diseases Chronic kidney disease
Chronic respiratory conditions Corporate publications Data linkage Data standards Deaths Dental & oral health Diabetes Disability Expenditure Eye health Food & nutrition General practice Health indicators Homelessness Hospitals Housing assistance Indigenous Australians Indigenous housing
Injury Life expectancy Male health Mental health services Mothers & babies National health priority areas Overweight & obesity Palliative care Population health Primary health carePrisoner health Risk factors Rural health Safety & quality of health care Veterans' health Workforce Youth health & wellbeing Youth justice
In other sections Subjects Data Contact AIHW
About AIHW data METeOR—metadata online registry Data by subject Catalogue of holdings of AIHW data Customised data analysis request Data governance framework Data linking Data standards GovHack Privacy of data Accessing Australian Government health and welfare data
By subjectAboriginal and Torres Strait Islander Health Performance Framework Adoptions Aged care Alcohol and other drugs Alcohol data sources Body weight data sources Cancer Children's headline indicators (CHI) Child protection Chronic disease indicators Data sources for monitoring health conditionsDeaths Disability
Expenditure FHBH - Fixing houses for better health General Record of Incidence of Mortality (GRIM) books Height and weight data sources Hospitals Indigenous Australians International collaboration Maternity Information Matrix (MIM) Medical indemnity Mental health Mortality Over Regions and Time (MORT) books National Aged Care Data Clearinghouse
National core maternity indicators (NCMI) National framework for protecting Australia’s children (NFPAC) National indicator catalogue National Youth Information Framework (NYIF) Perinatal data Primary Health Network (PHN) Specialist Homelessness Services (SHS) Tobacco data sources Workforce
In other sections Subjects Publications Contact AIHW
AACR ACFADD AHSAC AIHW Board AIHW Ethics Committee AODTS NMDS WG CKDMAC CMAG CSDWG CVDMAC HEAC
IGIHM JJ RIG MHISSC NAGATSIHID NCIAG NCSIMG NDDWG NDIMG NHISSC NIAG NIRAPIMG NMDD
NMDS NMHPSC NOPSAD NPDDC NPHEP NPHIC PCDWG PDWG PHIDG PHIG REDWG Workforce committees YIAG
Education worksheets Infographics What's in the pipeline Subscribe to education notices Other educational links
Resources by subject All Latest Ageing Australia's health Australia's welfare Carers
Children & youth Disability Disease Drugs
Health Health prevention Indigenous Australians Injury
In other sections Subjects Data Publications Contact AIHW
Job vacancies How to apply for a position at the AIHW Conditions of employment Benefits of working for the AIHW Temporary employment register Occupational Training Program Contact the People Unit Graduates
AIHW Access magazine Media releases Subscribe to release notices Embargoed access to AIHW material Media contacts
You are here:
The number of Australians receiving pharmacotherapy treatment for dependence on opioid drugs such as heroin continues to rise, and the proportion of older clients is also increasing, according to a report released today by the Australian Institute of Health and Welfare (AIHW).
The findings of the National Opioid Pharmacotherapy Statistics Annual Data Collection: 2010 report show that on a snapshot day in 2010 there were over 46,000 clients who received pharmacotherapy for opioid dependence.
‘There was a rise of just over 2,600 clients between 2009 and 2010 which is consistent with the growth of pharmacotherapy treatment we have seen in recent years,’ said Amber Jefferson of the AIHW’s Drug Surveys and Services Unit.
‘Since 2006, there has been a shift towards older clients receiving treatment, with the proportion of clients aged 30 years and over rising from 72% to 82% and the proportion of clients aged under 30 falling in 2010.’
‘While the number of clients receiving pharmacotherapy for opioid dependence increased in 2010, the number of clients below the age of 30 has dropped since 2006.’
‘The ratio of male to female clients has remained the same over recent years, with males making up about two-thirds of all clients,’ Ms Jefferson said.
Also consistent with findings in previous years, methadone was the most common pharmacotherapy drug, with close to 7 out of 10 clients receiving this form of treatment. The remaining clients received either buprenorphine or buprenorphine/naloxone.
‘There was a small rise in the number of dosing point sites in Australia, up from 2,157 in 2009 to 2,200 in 2010,’ Ms Jefferson said.
Most opioid pharmacotherapy dosing point sites were located in pharmacies.
The number of clients per dosing point site across Australia has been rising slowly in recent years, with 21 clients per dosing site in 2010 compared with 19 in 2006.
The AIHW is a major national agency set up by the Australian Government to provide reliable, regular and relevant information and statistics on Australia’s health and welfare.
Canberra, 22 June 2011
Further information: Ms Amber Jefferson, AIHW, tel. (02) 6244 1137, mob. 0418 271 395
For media copies of the report: Publications Officer 02 6244 1032
Full report: National Opioid Pharmacotherapy Statistics Annual Data Collection: 2010 report